Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma

被引:14
|
作者
Brundler, MA
Harrison, JA
de Saussure, B
de Perrot, M
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[3] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[4] Unitas Hosp, NetCare Mol Med Inst, ZA-0140 Pretoria, South Africa
关键词
D O I
10.1136/jcp.2005.028118
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Oesophageal adenocarcinoma is an aggressive neoplasm with poor prognosis as a result of early lymph node metastasis. Aims: To measure lymphatic vessel density (LVD) in the neoplastic progression from Barrett's metaplasia to adenocarcinoma and determine whether LVD can predict the risk of cancer. In addition, to correlate LVD with lymph node metastasis and assess whether LVD could be used as a prognostic indicator for outcome or survival. Methods: LVD and microvascular density (MVD) were assessed after immunohistochemical staining of vessels in Barrett's metaplasia, dysplasia, and adenocarcinoma tissues and were correlated with clinicopathological features. Results: LVD was significantly reduced in adenocarcinoma, being half that seen in normal stomach/oesophagus or metaplasia/dysplasia. LVD did not correlate with tumour grade, stage, or clinical outcome; however, patients who had either lymph node metastasis or invasion of tumour cells into peritumorous lymphatic vessels had a significantly worse overall survival. MVD was also assessed as a prognostic marker; its increase appeared to be linked more with the development of Barrett's metaplasia than adenocarcinoma. Conclusions: The reduction in lymphatic vessel numbers was not useful for determining disease outcome in the patient group studied. It is the entry of tumour cells into pre-existing peritumorous lymphatic vessels that confers a significantly worse overall survival.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [31] Adenocarcinoma progression in Barrett Oesophagus, association with DNA methylation changes
    Valero Torres, A.
    Hoerndler, C.
    Chueca, E.
    Lozano, J. J.
    Garcia Gonzalez, M. A.
    Strunk, M.
    Lanas, A.
    Roche, B.
    Gurrea Vidal, N.
    Torrecilla Idoipe, N.
    Piazuelo, E.
    VIRCHOWS ARCHIV, 2014, 465 : S147 - S147
  • [32] Epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
    Perez, Nancy
    Taylor, William
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2019, 35 (01) : 61 - 68
  • [33] Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus
    Kastelein, Florine
    Biermann, Katharina
    Steyerberg, Ewout W.
    Verheij, Joanne
    Kalisvaart, Marit
    Looijenga, Leendert H. J.
    Stoop, Hans A.
    Walter, Laurens
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    Bruno, Marco J.
    HISTOPATHOLOGY, 2013, 63 (05) : 630 - 639
  • [34] Goblet Cell Density and Risk of Neoplastic Progression in Barrett's Esophagus
    Bansal, Ajay
    McGregor, Douglas H.
    Rao, Deepthi S.
    Singh, Mandeep
    Gaddam, Srinivas
    Cherian, Rachel
    Anand, Oksana
    House, John
    Shipe, Tracy
    Singh, Vikas
    Wani, Sachin B.
    Gupta, Neil
    Rasiogi, Amit
    Sharma, Prateek
    GASTROENTEROLOGY, 2011, 140 (05) : S306 - S306
  • [35] Hallmarks of cancer progression in Barrett's oesophagus
    Morales, CP
    Souza, RF
    Spechler, SJ
    LANCET, 2002, 360 (9345): : 1587 - 1589
  • [36] Molecular changes in the progression of Barrett's oesophagus
    Zagorowicz, Edyta
    Jankowski, Janusz
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (982) : 529 - 535
  • [37] Neoplastic progression in Barrett's esophagus
    Barrett, MT
    Sanchez, CA
    Galipeau, PC
    Neshat, K
    Cowan, DS
    Levine, DS
    Reid, BJ
    GENOMIC INSTABILITY AND IMMORTALITY IN CANCER, 1997, 8 : 195 - 214
  • [38] Large polypoid adenocarcinoma of the oesophagus arising from Barrett's oesophagus
    Kanda, Mumta
    Graebner, Lennart
    Mukherjee, Samrat
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 87 - 87
  • [39] Deoxycholic acid drives mitochondrial instability during progression of Barrett's oesophagus to oesophageal adenocarcinoma
    O'Farrell, N. J.
    Fox, E. J.
    Feighery, R.
    Picardo, S. L.
    Casey, R.
    Lynam-Lennon, N.
    Biniecka, M.
    O'Sullivan, J. N.
    Reynolds, J. V.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 36 - 36
  • [40] Deoxycholic acid drives mitochondrial instability during progression of Barrett's oesophagus to oesophageal adenocarcinoma
    O'Farrell, N. J.
    Fox, E. J.
    Feighery, R.
    Picardo, S. L.
    Casey, R.
    Lynam-Lennon, N.
    O'Sullivan, J. N.
    Reynolds, J. V.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : 19 - 19